Professor Barry Potter wins 2009 GlaxoSmithKline International Achievement Award

Professor Barry Potter, Professor of Medicinal & Biological Chemistry in the Department of Pharmacy & Pharmacology, and the late Professor Michael Reed, from Imperial College, London, have won the prestigious 2009 GlaxoSmithKline (GSK) International Achievement Award.

Professor Potter delivered the award-winning lecture, entitled “Steroid Sulfatase Inhibitors: from Concept to Clinic,” and received a cheque for £1,000 on Wednesday 9 September at the British Pharmaceutical Conference, the Royal Pharmaceutical Society’s annual flagship conference.

The researchers achieved the award in recognition of their discovery of a new family of anti-cancer drugs called steroid sulfatase inhibitors. These are currently being explored by the pharmaceutical company Ipsen in several clinical trials as a  “First-in-Class” therapy, as a treatment for breast cancer and a potential treatment for other tumours.

The pair were selected by a review panel of senior staff from GSK for their advancements in the application of scientific knowledge within the pharmaceutical sciences.

Professor Potter and Professor Reed worked together for more than 18 years, pursuing a common interest of novel drug discovery and development. They published together extensively and formed a university spin-out company to exploit their drug candidates.

Previous winners of this award have included scientists from the USA, UK, Sweden, France & Australia.

Professor Potter said: "Winning the GSK International Achievement Award is a great honour and a most welcome recognition of the interdisciplinary work that Professor Reed and I have led for almost two decades.

"Modern clinical drug discovery is a team effort and rarely achieved in academia. This award also reflects the work of talented scientific colleagues at both institutions whose contributions are warmly acknowledged."

Bookmark with:

What is this?

We are one of the UK's leading universities with an international reputation for quality research and teaching. Our Mission is to deliver world class research and teaching, educating our graduates to become future leaders and innovators, and benefiting the wider population through our research, enterprise and influence. Our courses are innovative and interdisciplinary and we have an outstanding record of graduate employment.